Home > Insider Trading > Filing (0001209191-21-034628)

Filing Details

Accession Number:: 0001209191-21-034628
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-05-20 19:21:20
Reporting Period:: 2021-05-18

Accepted Time:: 2021-05-20 19:21:20
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808158	Repare Therapeutics Inc.	RPTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1473930	Todd Foley	C/O Mpm Capital 450 Kendall Street Cambridge MA 02142		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Shares	Disposition	2021-05-18	6,509	$33.90	2,596,580	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-18	3,763	$34.61	2,592,817	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-18	40	$35.14	2,592,777	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-18	21,834	$0.00	2,570,943	No	4	J	Indirect	See Footnote
Common Shares	Disposition	2021-05-19	4,029	$34.23	2,566,914	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-19	1,939	$35.00	2,564,975	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-20	4,122	$34.66	2,560,853	No	4	S	Indirect	See Footnote
Common Shares	Disposition	2021-05-20	265	$35.19	2,560,588	No	4	S	Indirect	See Footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	J	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote
No	4	S	Indirect	See Footnote

Footnotes

Transaction effected pursuant to a plan established pursuant to Rule 10b5-1 on 3/31/2021.
The shares were sold as follows: 6,292 by MPM BioVentures 2014, L.P. ("BV 2014") and 217 by MPM Asset Management Investors BV2014 LLC ("AM BV2014").
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.06 to$34.05 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,357,748 by BV 2014, 157,677 by MPM BioVentures 2014(B), L.P. ("BV 2014(B)") and 81,155 by AM BV2014. MPM BioVentures 2014 GP LLC and MPM BioVentures 2014 LLC ("BV LLC") are the direct and indirect general partners of BV 2014 and BV 2014(B). BV LLC is the manager of AM BV2014. Todd Foley is a managing director of BV LLC. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 3,638 by BV 2014 and 125 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.07 to$35.01 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,354,110 by BV 2014, 157,677 by BV 2014(B) and 81,030 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 39 by BV 2014 and 1 by AM BV2014.
The shares are held as follows: 2,354,071 by BV 2014, 157,677 by BV 2014(B) and 81,029 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Represents a pro rata in-kind distribution from BV 2014(B) to its limited partners for no consideration.
The shares are held as follows: 2,354,071 by BV 2014, 135,843 by BV 2014(B) and 81,029 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 3,895 by BV 2014 and 134 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.70 to$34.64 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,350,176 by BV 2014, 135,843 by BV 2014(B) and 80,895 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 1,874 by BV 2014 and 65 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.74 to$35.25 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,348,302 by BV 2014, 135,843 by BV 2014(B) and 80,830 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 3,985 by BV 2014 and 137 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.10 to$35.04 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,344,317 by BV 2014, 135,843 by BV 2014(B) and 80,693 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
The shares were sold as follows: 256 by BV 2014 and 9 by AM BV2014.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.14 to$35.22 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth inthis footnote.
The shares are held as follows: 2,344,061 by BV 2014, 135,843 by BV 2014(B) and 80,684 by AM BV2014. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.